Monday 06 May, 2024 12:12 PM
Site map | Locate Us | Login
   Britannia Inds Q4 PAT drops 4% YoY to Rs 537 cr    CRISIL upgrades ratings of Seamec to 'A+' with 'stable' outlook    Kotak Mahindra Bank soars PAT rises 18% YoY in Q4    MRPL tumbles as Q4 PAT drops 40% YoY to Rs 1,137 cr; GRM reduces to $11.35/ barrel    Volumes soar at Britannia Industries Ltd counter    Titan Company slips after Q4 PAT drops 24% QoQ to Rs 786 cr    CDSL jumps after Q4 PAT soars to Rs 129 cr; declares dividend of Rs 22/ share    Tata Tech slips after Q4 PAT slides to Rs 157 cr    Avenue Supermarts Q4 PAT climbs 22% YoY to Rs 563 cr    DCM Shriram commissions Caustic Soda capacity at Bharuch    Angel One client base climbs 63% YoY in April    Healthcare stocks edge higher    Banking stocks rise    Information Technology shares rise    Dr Reddy's Labs launches generic Oracea capsules in US markets 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Zydus Life declines after US FDA concludes manufacturing facility inspection with 10 observations
24-Apr-24   13:24 Hrs IST

In an exchange filing made during market hours today, the pharmaceutical company stated that the USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from 15 April 2024 to 23 April 2024.

The company further informed that the said inspection has closed with 10 observations.

The company will closely work with the US FDA to address and respond to the observations in an expeditious manner,? Zydus Lifesciences said in a statement.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The pharmaceutical company reported 26.76% increase in consolidated net profit of Rs 789.6 crore on 5.83% rise in revenue from operations to Rs 4,343.70 crore in Q3 FY24 over Q3 FY23.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR Hit Count : 32413744
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd